110 related articles for article (PubMed ID: 11478407)
1. Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines.
Lishner M; Bar-Sef A; Elis A; Fabian I
J Investig Med; 2001 Jul; 49(4):319-24. PubMed ID: 11478407
[TBL] [Abstract][Full Text] [Related]
2. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
3. [Effect of 2-chlorodeoxyadenosine, arabinoside cytosine and doxorubicin on acute myeloid leukemia clonogenic cell proliferation].
Sawiński K; Hansz J; Kozłowska-Skrzypczak M
Acta Haematol Pol; 1995; 26(3):279-84. PubMed ID: 8525773
[TBL] [Abstract][Full Text] [Related]
4. Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo.
Wang YF; Curtis JE; Lipton J; Minkin S; McCulloch EA
Leukemia; 1991 Jun; 5(6):522-7. PubMed ID: 1711641
[TBL] [Abstract][Full Text] [Related]
5. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin, an inhibitor of cholesterol biosynthesis, shows a synergistic effect with N,N'-bis(2-chloroethyl)-N-nitrosourea and beta-interferon on human glioma cells.
Soma MR; Pagliarini P; Butti G; Paoletti R; Paoletti P; Fumagalli R
Cancer Res; 1992 Aug; 52(16):4348-55. PubMed ID: 1643632
[TBL] [Abstract][Full Text] [Related]
7. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
8. A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside.
Rayappa C; McCulloch EA
Leukemia; 1993 Jul; 7(7):992-9. PubMed ID: 8321050
[TBL] [Abstract][Full Text] [Related]
9. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
10. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
Koistinen P; Wang C; Curtis JE; McCulloch EA
Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
[TBL] [Abstract][Full Text] [Related]
12. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
[TBL] [Abstract][Full Text] [Related]
14. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity.
Yang GS; Wang C; Minden MD; McCulloch EA
Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994
[TBL] [Abstract][Full Text] [Related]
16. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
17. Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside.
Yoon JS; Kim ES; Park BB; Choi JH; Won YW; Kim S; Lee YY
Int J Oncol; 2015 May; 46(5):1953-62. PubMed ID: 25695330
[TBL] [Abstract][Full Text] [Related]
18. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
Curtis JE; Minkin S; Minden MD; McCulloch EA
Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892
[TBL] [Abstract][Full Text] [Related]
19. Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patients.
van der Weide K; de Jonge-Peeters S; Huls G; Fehrmann RS; Schuringa JJ; Kuipers F; de Vries EG; Vellenga E
Exp Hematol; 2012 Mar; 40(3):177-186.e6. PubMed ID: 22120639
[TBL] [Abstract][Full Text] [Related]
20. Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples.
van der Weide K; de Jonge-Peeters SD; Kuipers F; de Vries EG; Vellenga E
Clin Cancer Res; 2009 May; 15(9):3076-83. PubMed ID: 19383813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]